Figure S2
(A) Brain tumor penetrance is shown by the ratio of 'the number of the mice sacrificed due to brain tumors' to 'the total number of mice analyzed within the cohorts'. Mice without brain tumors were sacrificed due to other health-concerning reasons, including soft-tissue sarcomas, paralysis, spinal cord tumors, eye problems, prolapse, dermatitis and other poor health conditions. Fisher's exact test was used to compare the groups in terms of the frequency of mutant mice 'with brain tumors' versus 'without brain tumors'. (B) Kaplan-Meier survival curves of the mice that were sacrificed due to body tumor formation without any brain tumors or brain abnormalities. The Mantel-Cox (Log-rank) test was used to compare the survival curves statistically. (C) Histopathological analyses of p53 Δ5-6 driven malignant gliomas using p53, Olig2, GFAP and Synaptophysin antibodies. Multipolar or abnormal mitoses (i, iii and xii), multinucleated giant cells (ii, iv, vi, vii and xiv) , mitotic figures (x and xiii), and vascular proliferation (xv) are noted.
(D) The total number of the p53 Δ5-6 -positive cells remaining in the germinal zone (SVZ/RMS) was quantified in 6-7 months old p53 Δ5-6/Δ5-6 and p53
Δ5-6/Δ5-6 Rictor Δ/Δ mice. The proliferation percentages of the p53 Δ5-6 -positive cells (i.e. BrdU + p53 Δ5-6 -positive/p53 Δ5-6 -positive) were calculated using samples with at least 10 or more p53 Δ5-6 -positive cells. (E) Genotyping of the malignant glioma samples from p53 Δ5-6/Δ5-6 , p53
Δ5-6/Δ5-6 Rictor
, and p53 Δ5-6/Δ5-6 Rictor Δ/Δ mice. Normal brain tissue from a hGFAP-cre;p53 +/flox ;Rictor +/flox mouse was used as a positive control (Ctr) to show the PCR bands of wild-type allele and floxed allele of p53 and Rictor genes. Cre-negative normal brain tissue was used as a negative control (Ctr) for the PCR band of Cre allele. (F) Western blot analysis of the malignant gliomas from p53 Δ5-6/Δ5-6 (n = 4), p53
Δ5-6/Δ5-6
Rictor +/Δ (n = 8), and p53 Δ5-6/Δ5-6 Rictor Δ/Δ (n = 8) mice along with a normal cerebral cortex tissue (CTR) and malignant gliomas from the glioma model that harbors p53 and Pten mutations (p53 , details about this model is shown in Figure S3D ). All quantification data are presented as mean ± SEM. Two-tailed Fisher's exact test was used to compare the groups (A). The Mantel-Cox (Log-rank) test was used to compare the survival curves statistically (B). Scale bars, 25 µm. , p53 ). Wild-type cerebellar tissue was used as a control (CTR), and two malignant glioma samples from p53 Δ5-6/Δ5-6 Rictor +/Δ and p53 Δ5-6/Δ5-6 Pten +/Δ (last two lanes) mice were also included in the analysis. (B) Brain tumor distribution and survival curves of p53-mutant mice with brain tumors among different cohorts. Note that mice with MBs (labeled with "blue/green-like" curves) succumbed to death earlier than the mice with malignant glioma (labeled with "pink/red-like" curves) in all cohorts and models. In addition, the penetrance of the MBs is less than 11% in all models, except for p53
, which has up to 52% MB penetrance. Lastly, p53
Δ5-6/Δ5-6 Rictor Δ/Δ mice with malignant gliomas lived significantly longer than any of the other p53-mutant mouse models with malignant gliomas (comparison of pink/red curves), p < 0.0001. (C and D) Genetic configuration of p53 Δ5-6/Δ5-6 , p53
, and p53 Δ5-6/Δ5-6 Rictor Δ/Δ mice (C) and p53 Δ5-6/Δ5-6 Pten
Δ5-6/Δ5- + cells that were located in ML (J) or proliferating in EGL-associated areas (K) was quantified in three folia (Folia-5/6, Folia-9/10a, and Folia-10b). p-values for several comparisons are shown in (L). All quantification data presented as mean ± SEM. Unpaired Student's t-test was used to compare the groups statistically. Scale bars, 100 µm. EGL, External Granular Layer; ML, Molecular Layer; IGL, Internal Granular Layer. + cell number was quantified in all EGLs (I) and only in Folia-6&7 (J), related to Figure 5C . (K and L) Representative H&E staining of cerebella from vehicle-or BKM120-treated mice. Areas marked with Roman numbers indicate Folia-6, Folia-7, and Folia-8 (K). High magnification images of marked areas in F-6a/6b, F-6b/7, and F-7/8 are also shown (L). Arrowheads indicate the retained cells in EGL.
(M) p53
Δ5-6/Δ5-6 medulloblastoma cell line was treated with DMSO and BKM120 (0.1µM) for different time periods as indicated. Then, CellTiter-Glo luminescent cell viability analysis was performed. For each time point, the ratio of BKM120 group/DMSO group was calculated.
(N) p53
Δ5-6/Δ5-6 medulloblastoma cell line was treated with BKM120 (0.1µM) for different time periods as indicated. Then, the cells were collected and subjected to -qPCR analysis to determine Atoh1 mRNA levels. Four repeated experiments were analyzed. All quantification data presented as mean ± SEM. Unpaired Student's t-test was used to compare the groups statistically in (C, E, F, H, I, J). (F) Low-coverage whole genome sequencing (lcWGS) plots depicting the copy number alterations (CNAs) in chr12, chr1, and the entire genome of p53-mutant driven MBs. The low-level N-Myc amplification/gain (sample G3), chr12 gain (samples C4 and E1), and low-level Gli2 amplification/gain (sample B4) are colored in red. X-axes specify the location within each chromosome. Y-axes indicate the number of read per 1 kb normalized to total reads. This parameter is shown as a ratio of tumor versus control tissue. Baseline is shown with a red line across the plots. Red frames label the chromosomal regions with gains/amplifications. (G-L) lcWGS plots of whole genome or chr13 and chr19 in two p53-mutant driven mouse MBs with Rictor deletions. X-axes specify the location within each chromosome. Y-axes indicate the number of read per 1 kb normalized to total reads. This parameter is shown as a ratio of tumor versus control tissue. Baseline is shown with a red line across the plots. Blue shades and frames label the chromosomal regions with losses while the red shades and frames label the chromosomal regions with gains/amplifications. chr13 and chr19 are framed by blue and/or red rectangles in (G and J), and they are shown in higher magnification (H and K for chr13 and I and L for chr19). The approximate locations of Ptch1 (H and K) and Pten (I and L) genes are indicated with arrows. (M) The frequencies of each copy number alterations exemplified in (F-L) were calculated and presented in relation to their Rictor genotype. The actual numbers of the events are shown, and the ratios are presented as percentages in parentheses. Fisher's exact test was used to compare the groups statistically in (E). Scale bars, 50 µm. EGL, External Granular Layer.
